PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors

Authors

Amanda M. Smith, Washington University School of Medicine in St. Louis
Christine R.C. Zhang, Washington University School of Medicine in St. Louis
Alexandre S. Cristino, The University of Queensland
John P. Grady, The University of Queensland
J Lynn Fink, The University of Queensland
Andrew S. Moore, Washington University School of Medicine in St. Louis

Journal

Oncotarget

Publication Date

10-8-2019

Volume

10

Issue

56

First Page

5755

Last Page

5767

Document Type

Open Access Publication

DOI

10.18632/oncotarget.27206

Rights and Permissions

Smith AM, Zhang CRC, Cristino AS, Grady JP, Fink JL, Moore AS. PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors. Oncotarget. 2019 Oct 8;10(56):5755-5767. doi: 10.18632/oncotarget.27206. eCollection 2019 Oct 8. Copyright: Smith et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Smith, Amanda M.; Zhang, Christine R.C.; Cristino, Alexandre S.; Grady, John P.; Fink, J Lynn; and Moore, Andrew S., "PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors." Oncotarget. 10, 56. 5755 - 5767. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8578